Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferiprone in PKAN
NCT01741532Phase 3Completed
- Sponsor
- ApoPharma Inc.
- Start
- Dec 2012
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of deferiprone in pantothenate kinase-associated neurodegeneration (PKAN), sponsored by ApoPharma Inc.. Started Dec 2012; status: completed.
02
Drugs
deferiprone
03
Conditions
pantothenate kinase-associated neurodegeneration (PKAN)
Beyond the preview
Go deeper on NCT01741532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741532.